Health

COVID-19: EU Still Testing Pfizer Vaccine, Keeps 2021 Forecast

The European Medicines Agency is still reviewing the safety of a Covid-19 vaccine submitted by Pfizer and BionNTech and has not received clinical trial data, EU sources said Monday.

A “rolling review” of several potential vaccines is underway and, for now, Brussels is sticking by its forecast that one may be approved and available “early next year”, one source said.

Earlier, the companies said that ongoing trials had found that their vaccine was 90 percent effective in preventing Covid-19 infections, sending hopes soaring for an end to the epidemic.

The European Medicines Agency (EMA) has begun an expedited procedure to examine potential vaccines, and did nothing to pour cold water on reports of a breakthrough.

But a spokeswoman for the Amsterdam-based agency said they had yet to receive the results of clinical trials.

“Through rolling reviews, EMA can exceptionally evaluate data as it becomes available, ahead of a formal marketing-authorisation application,” she said.

“We evaluated the first batch of data on the vaccine, which came from laboratory studies (non-clinical data).

“The agency is currently assessing a second batch of data which relate to the quality of the vaccine, including data related to its ingredients and the way it is produced.

“Any new data available for this vaccine will be reviewed in the same way. We have not received nor assessed the emerging clinical data at this point and can therefore not comment further.”

Separately, in Brussels, a European source confirmed this and added “any prediction would be risky, but we have good indications that the first vaccine may be available early next year.”

European officials, including the president of the European Commission Ursula von der Leyen have previously used this timeline when talking about a future vaccine.

And Brussels has put funding aside to reserve tens of millions of doses of future vaccines from several companies, including that from US giant Pfizer and its German partner BioNTech.

AFP

admin

Recent Posts

FG Lifts Five-Year Ban on Mining in Zamfara, Eyes Economic Boost

The Federal Government has officially lifted the five-year ban on mining activities in Zamfara State,…

26 minutes ago

Death Toll Rises to 22 in Anambra Stampede, As Police Begin Investigation

  The death toll from a tragic stampede in Anambra State has risen to 22,…

55 minutes ago

NNPCL Refutes Shutdown Claims: Port Harcourt Refinery Fully Operational

  The Nigerian National Petroleum Company Limited (NNPCL) has dismissed media reports suggesting that the…

21 hours ago

Grim Friday: Man, Wife, Grandson Perish in Ibadan Fire

  A devastating house fire in the Ori-Eru area of Idikan, Ibadan, Oyo State, has…

21 hours ago

Human Rights Lawyer, Dele Farotimi, Granted ₦30m Bail

A Magistrate Court sitting in Ado Ekiti, the Ekiti State capital, has granted human rights…

2 days ago

Bank Robberies Now History in Lagos Since 2014 – IGP

    The Inspector General of Police, Kayode Egbetokun, has declared that the era of…

2 days ago